Skip to content

Epidemiological Study for Bronchopulmonary Dysplasia (BPD) in China

The Incidence, Risk Factors, Diagnosis, Treatments and Burden of Bronchopulmonary Dysplasia (BPD) Among Very Preterm Infants in China: A Nationwide Prospective Cohort Study.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03850457
Enrollment
3800
Registered
2019-02-21
Start date
2020-01-01
Completion date
2024-03-31
Last updated
2025-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchopulmonary Dysplasia

Keywords

bronchopulmonary dysplasia, preterm infants, epidemiologic characteristics, risk factors, mortality

Brief summary

This study will establish a nationwide cohort of very preterm infants in China, to investigate the epidemiological characteristics and short-term outcomes of BPD in different NICUs around the country.

Detailed description

This is a nationwide multicenter prospective cohort study of very preterm infants in China. We will collect general information of very preterm infants, maternal and obstetrical conditions, resuscitation strategies in delivery room, diagnosis of BPD, treatments and complications from medical record review and family interviews. This study aims to 1) investigate the epidemiologic characteristics of BPD based on the National Institutes of Health consensus definition in 2000 and 2016 respectively, and compare the applicability of two standard criteria for BPD in China; 2) identify independent risk factors for the development of BPD, such as ethnicity, gender, gestational age, birth weight, maternal and obstetrical conditions, fetal conditions, chorioamnionitis, infection, anemia, PDA, early pulmonary hypertension and so on; 3) establish prediction models of BPD at different postnatal ages; 4) investigate the short-term outcomes of BPD, such as mortality in NICU, LOS, late pulmonary hypertension, and so on; 5) investigate the prevention and treatment measures of BPD and evaluate the implementation of high evidence practices to reduce mortality and BPD, such as using antenatal steroids and caffeine; 6) investigate economic burden of BPD in China. This program is organized by the steering committee, on which each clinical center and data coordinating center are represented. Each center will contribute to data collection and coordination. The steering committee will hold a conference call every month, meet in-person twice yearly and additionally hold working meetings at the Congress of Chinese Pediatric Society and the Congress of Chinese Neonatal Society. The committee will identify and resolve issues, encourage the centers to finish their work better. The data coordinating center will manage clinical report forms, provide support for standardization of definitions, data collection and quality control. The data coordinating center will hold training webinars with the research team from each site to ensure uniform approaches to data collection before study inception. A centralized research electronic data capture system (by Suirong Corporation, Shanghai, China) will be used in this study. Each site will contribute data using a computer-based interface. Individual centers will retain access to their own data through customized downloads from the database management tool. Data cleaning and statistical analysis will be conducted by an independent epidemiology & statistics work group from Children's Hospital of Fudan University and Public Health School of Fudan University. The study protocol and consent forms were evaluated by the institutional review board (IRB) of Fudan University. The protocol, questionnaire, statistical analysis plan and IRB approvals will be accessible on the website of China Neonatal Network.

Interventions

OTHERNo intervention

The treatments will be determined by their neonatologists and no additional investigational drugs will be applied to the infants included in this study.

Sponsors

Shengjing Hospital
CollaboratorOTHER
Beijing Children's Hospital
CollaboratorOTHER
Inner Mongolia Maternity and Child Health Care Hospital
CollaboratorUNKNOWN
Shanxi Provincial Maternity and Children's Hospital
CollaboratorOTHER
Qilu Children's Hospital of Shandong University
CollaboratorOTHER
The Affiliated Hospital of Qingdao University
CollaboratorOTHER
Yantai Yuhuangding Hospital
CollaboratorOTHER
Shanghai Children's Medical Center
CollaboratorOTHER
Shanghai First Maternal and Infant Health Hospital affiliated to Tongji University Medical School
CollaboratorOTHER
The First Affiliated Hospital with Nanjing Medical University
CollaboratorOTHER
Nanjing Maternity and Child Health Care Hospital
CollaboratorOTHER
The First Affiliated Hospital of USTC
CollaboratorUNKNOWN
Anhui Provincial Children's Hospital
CollaboratorOTHER
Yuying Children's Hospital of Wenzhou Medical College
CollaboratorUNKNOWN
Ningbo Women & Children's Hospital
CollaboratorOTHER
QuanZhou Women and Children's Hospital
CollaboratorOTHER
Xiamen Maternity and Child Health Care Hospital
CollaboratorUNKNOWN
The First Affiliated Hospital of Zhengzhou University
CollaboratorOTHER
Children's Hospital of Zhengzhou University
CollaboratorUNKNOWN
Hubei Maternity and Child Health Care Hospital
CollaboratorUNKNOWN
Hunan Children's Hospital
CollaboratorOTHER_GOV
Foshan Maternity and Child Health Care Hospital
CollaboratorUNKNOWN
Maoming Maternity and Child Health Care Hospital
CollaboratorUNKNOWN
Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region
CollaboratorOTHER
Northwest Women's and Children's Hospital, Xi'an, Shaanxi
CollaboratorOTHER
Gansu Provincial Maternal and Child Health Care Hospital
CollaboratorOTHER
First Affiliated Hospital of Xinjiang Medical University
CollaboratorOTHER
Xinjiang People's Hospital
CollaboratorUNKNOWN
Chengdu Women and Children's Center Hospital
CollaboratorOTHER
Guizhou Maternity and Child Health Care Hospital
CollaboratorUNKNOWN
The Affiliated Hospital of Zunyi Medical College
CollaboratorUNKNOWN
Children's Hospital of Fudan University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 28 Days
Healthy volunteers
No

Inclusion criteria

* Infants with GA less than 32 weeks; * Admitted to member neonatology centers during the period of recruitment; * Age at admission less than 28 days.

Exclusion criteria

* Infants with major congenital anomalies, which include but not limited to serious congenital heart defects, chromosomal abnormalities, gastrointestinal atresias, brain malformations, congenital diaphragmatic hernia, renal agenesis or dysplastic kidneys; * Infants with inborn errors of metabolism; * Infants with severe heritable disease.

Design outcomes

Primary

MeasureTime frameDescription
Bronchopulmonary dysplasia36 weeks of postmenstrual ageDiagnosis by the standard criteria developed by NICHD in 2016 and 2000.
Mortality in NICUthrough study completion, an average of 3 monthsThe preterm infants who dies owing to persistent parenchymal lung disease or other diseases in NICUs.

Secondary

MeasureTime frameDescription
NICU length of stay (LOS)through study completion, an average of 3 monthsThe length of stay in NICU (days)
Hospital coststhrough study completion, an average of 3 monthsThe total costs in NICU (yuan)
Other complicationsthrough study completion, an average of 1 yearSuch as NRDS, ROP, NEC, PDA, IVH, pneumothorax, pulmonary hypertension, pneumonia, apnea, hyperbilirubinemia, sepsis, anemia, CNS infection, and so on. All the complications will be diagnosed by the standard criteria made by China Neonatal Network.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026